Replimune (REPL) won over the FDA to submit a marketing application for its lead asset RP1 for the third time despite previous rejections, thanks to the intervention of White House officials, The Wall ...

A global conservation observance enters its 26th year this week with a new website, expanded resources and a renewed push to grow its international reach — all as scientists warn that more than half ...

High schooler Evan Budz's award-winning invention can identify coral bleaching, invasive species, and microplastics without disturbing marine ecosystems. By Laura Kiniry Published May 12, 2026 9:01 AM ...

The website for the popular JDownloader download manager was compromised earlier this week to distribute malicious Windows and Linux installers, with the Windows payload found deploying a Python-based ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

The practice began in 1920s Western variety shows and spread to city speakeasies, but it faces increased scrutiny today—and pressure from conservation groups to make races safer for the reptiles. In ...

Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

Let's be honest, we're all drama queens sometimes. Whether you're texting your bestie you're “literally dying” over the latest celebrity gossip or declaring on social media that Monday mornings are ...

It started with the mysterious discovery of more than a hundred turtles, some with their shells smashed, others dismembered, all of them dead. It ended with a potential warning for the future. It was ...

"We are hopeful for her recuperation and eventual release back into the Gulf," officials said Charlotte Phillipp is a Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and was ...

Shares of Replimune Group, Inc. (REPL Quick Quote REPL - Free Report) have gained 2.7% over the past four weeks to close the last trading session at $7.16, but there could still be a solid upside left ...